Citius Pharmaceuticals (NASDAQ: CTXR) CEO: Myron Holubiak About: Citius Pharmaceuticals (NASDAQ: CTXR) is a specialty pharmaceutical company dedicated to the development and commercialization of therapeutic products for large and growing markets. Citius products offer new and […]
“We are delighted to announce patients with type 2 diabetes in New Zealand now have access to V-Go® Wearable Insulin Delivery device,” said Valeritas CEO, John Timberlake. […]
Interview with Jeff Baxter, CEO […]
Phase 1 Demonstration of Safety and Long-Lasting Immune Responses in Ovarian and Breast Cancer […]
Interview with Dr. Lucy Lu, CEO and President […]
(NASDAQ: BIOC) […]
Interview with CEO Eric Adams […]
Interview with CEO John Hollister […]
Interview with CEO Andrew Morris […]
Management Interview […]
Copyright © 2019 The Wall Street Analyst, LLC. All rights reserved. Website by MyWebsiteSpot.com